Baxter International, Inc. (BAX)
26.50
+0.16
(+0.59%)
USD |
NYSE |
Aug 24, 16:00
26.29
-0.20
(-0.77%)
After-Hours: 20:00
Baxter International Enterprise Value : 20.30B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 20.30B |
| August 20, 2026 | 20.33B |
| August 19, 2026 | 20.45B |
| August 18, 2026 | 20.09B |
| August 17, 2026 | 20.08B |
| August 14, 2026 | 20.50B |
| August 13, 2026 | 20.66B |
| August 12, 2026 | 20.61B |
| August 11, 2026 | 20.95B |
| August 10, 2026 | 21.04B |
| August 07, 2026 | 20.92B |
| August 06, 2026 | 20.64B |
| August 05, 2026 | 20.81B |
| August 04, 2026 | 21.34B |
| August 03, 2026 | 21.21B |
| July 31, 2026 | 20.20B |
| July 30, 2026 | 20.51B |
| July 29, 2026 | 19.49B |
| July 28, 2026 | 19.28B |
| July 27, 2026 | 18.75B |
| July 24, 2026 | 18.26B |
| July 23, 2026 | 17.88B |
| July 22, 2026 | 17.92B |
| July 21, 2026 | 18.16B |
| July 20, 2026 | 18.09B |
| Date | Value |
|---|---|
| July 17, 2026 | 18.37B |
| July 16, 2026 | 18.75B |
| July 15, 2026 | 18.13B |
| July 14, 2026 | 17.95B |
| July 13, 2026 | 18.35B |
| July 10, 2026 | 18.37B |
| July 09, 2026 | 18.29B |
| July 08, 2026 | 18.04B |
| July 07, 2026 | 18.50B |
| July 06, 2026 | 18.35B |
| July 02, 2026 | 18.39B |
| July 01, 2026 | 17.89B |
| June 30, 2026 | 17.70B |
| June 29, 2026 | 19.02B |
| June 26, 2026 | 19.03B |
| June 25, 2026 | 18.77B |
| June 24, 2026 | 18.51B |
| June 23, 2026 | 18.02B |
| June 22, 2026 | 17.80B |
| June 18, 2026 | 17.92B |
| June 17, 2026 | 17.66B |
| June 16, 2026 | 18.21B |
| June 15, 2026 | 18.39B |
| June 12, 2026 | 18.42B |
| June 11, 2026 | 18.22B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DexCom, Inc. | 34.30B |
| Becton, Dickinson & Co. | 68.24B |
| Boston Scientific Corp. | 85.09B |
| West Pharmaceutical Services, Inc. | 24.74B |
| Abbott Laboratories | 229.49B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 135.00M |
| Revenue (Quarterly) | 2.96B |
| Total Expenses (Quarterly) | 2.825B |
| EPS Diluted (Quarterly) | 0.2432 |
| Gross Profit Margin (Quarterly) | 33.55% |
| Profit Margin (Quarterly) | 4.56% |
| Earnings Yield | -7.28% |
| Operating Earnings Yield | 4.72% |
| Normalized Earnings Yield | -1.553 |